Joinn Laboratories(China)Co.,Ltd.
603127
Classement en actions
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Prix de l'action
$6.82
Capitalisation boursière
$4.30B
Changement (1 jour)
-6.30%
Changement (1 an)
48.79%
Pays
CN
Échange Joinn Laboratories(China)Co.,Ltd. (603127)
Catégorie
Healthcare
Revenus pour Joinn Laboratories(China)Co.,Ltd. (603127)
Revenus en Oct 2026 TTM : 0
Selon les derniers rapports financiers de Joinn Laboratories(China)Co.,Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Joinn Laboratories(China)Co.,Ltd. de 2012 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2025 | $236.93M | -14.32% |
| 2024 | $276.52M | -17.64% |
| 2023 | $335.73M | 2.11% |
| 2022 | $328.79M | 37.79% |
| 2021 | $238.63M | 44.89% |
| 2020 | $164.70M | 79.37% |
| 2019 | $91.82M | 54.50% |
| 2018 | $59.43M | 28.34% |
| 2017 | $46.31M | 32.96% |
| 2016 | $34.83M | 9.47% |
| 2015 | $31.82M | 6.63% |
| 2014 | $29.84M | 25.84% |
| 2013 | $23.71M | 51.82% |
| 2012 | $15.62M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $47.35B | - |
US
|
|
| $25.61B | - |
US
|
|
| $2.71B | - |
US
|
|
| - | - |
CN
|
|
| $7.37B | - |
US
|
